Acupuncture and herbal medicine have traditionally been used in East Asia for cancer care. This study aimed to explore how acupuncture and herbal medicine in cancer treatment is used in Europe to identify the common cancer types treated, therapeutic methods applied, and patient satisfaction. This scoping review followed the Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews guideline and Arksey and O’Malley’s methodological framework. Literature searches were conducted using electronic databases and 2 complementary and alternative medicine-focused journals. The inclusion criteria included first author’s affiliation in Europe and use of acupuncture or herbal medicine in cancer treatment. The exclusion criteria included focusing solely on chemotherapy-related adverse effects or in vitro research. From 6,109 initial records, 6 studies met the inclusion criteria. Two studies involved acupuncture, and 4 involved herbal medicine. Breast cancer was the most frequently studied and ST36 was the most frequently used acupuncture point. Herbal medicines included mistletoe extract and Ruta graveolens. Reported outcomes included symptom relief and generally positivity, although findings varied. This scoping review identified a limited but emerging body of cancer research on the use of acupuncture and herbal medicine in Europe. Highquality clinical research is needed.
A patient living abroad who underwent catheter ablation for atrial fibrillation 3 years ago experienced recurrent arrhythmia symptoms 3 months ago and was diagnosed with premature ventricular complexes (PVCs) confirmed by Holter monitoring. He was advised to undergo repeat catheter ablation, however, he sought traditional Korean medicine (TKM) treatment advised via telemedicine. He reported continuous irregular heartbeats [numeric rating scale (NRS) score 10]. He was started on Yixin Tang, and by the 3rd day of administration his symptoms of irregular heartbeats had disappeared (NRS 0) and did not return during the subsequent 320-day observation period. Pain caused by tightness in the chest and throat (NRS 8) did not show improvement despite various prescriptions; a noncardiac etiology, likely gastrointestinal, was suspected. Heart failure as measured by NT-pro BNP levels, was consistently elevated borderline, around 130 pg/mL, (possible heart failure), and on Day 320 it was normal measuring 50 pg/mL (heart failure less likely). No serious adverse events were reported following TKM treatment. This case suggests the potential value of TKM remote treatment in meeting the unmet needs of arrhythmia patients. Further research, including controlled clinical trials and development of telemedicine-specific guidelines, is warranted.
While steroids effectively control inflammation, their long-term use causes severe side effects, necessitating safer alternatives. Schizonepeta tenuifolia (S. tenuifolia) from the Lamiaceae family demonstrates potential as a natural therapeutic option through its anti-inflammatory and antiviral properties. This systematic review analyzed in vivo and in vitro studies of S. tenuifolia extract, focusing on non-oral administration routes to evaluate its therapeutic potential (n = 13). The extract effectively inhibited nuclear factor kappa-light-chain-enhancer of activated B cells and mitogen-activated protein kinase pathways, reduced inflammatory cytokine production, and showed antiviral effects. Additional benefits include wound healing and antiplatelet activity which enables targeted inflammation control without systemic immune suppression. The extract showed promise in conditions requiring targeted pathway modulation, such as inflammatory conditions needing selective cytokine inhibition, viral infections where interferon modulation is beneficial, and disorders with dysregulated mitogen-activated protein kinase signaling. These effects were achieved without the systemic immunosuppression typical of steroid treatments. While S. tenuifolia extract could serve as a safer alternative through non-oral administration routes, further research is needed to optimize extraction methods, identify key marker compounds, and determine optimal administration routes including topical administration and injectable formulations.
Background Insufficient postpartum care can negatively affect mothers’ health. The aim of the Korean Medicine-based Postnatal Healthcare Program (KMPHP) is to prevent and treat Sanhupung by rapid intervention in postpartum care.
Methods A retrospective study was conducted using data from 37 postpartum women who participated in the KMPHP between April 2019 and April 2020. The women had received at least one type of Korean medicine treatment (herbal medicine, acupuncture, electroacupuncture, pharmacoacupuncture, or Chuna manual therapy) for at least one session. General characteristics were collected from the medical records, and postpartum symptoms (taken from a questionnaire) were investigated. Outcome measures included pain intensity, quality of life (QoL), and postpartum depression.
Results The effectiveness of the KMPHP was determined using the paired-sample Wilcoxon test and significant improvements in the scores were observed using the Korean version of the Edinburgh Postnatal Depression Scale (from 8 to 5, p < 0.01), EuroQol-5 Dimension-5L (from 0.82 to 0.83, p = 0.02), and EuroQol Visual Analog Scale (from 70 to 80, p < 0.01). The womens’ pain scores (Numeric Rating Scale) reduced from 4 to 3 after treatment, but the difference was not significant. As a result of analyzing the effects of each intervention, herbal medicine show a significant effect on womens’ depression, QoL and pain, and non-pharmacological intervention showed synergistic effects with herbal medicine.
Conclusion Korean medicine-based interventions may be effective in the management of postpartum health by improving mothers’ emotional status, QoL, as well as reducing pain.
Background Cancer remains a major public health threat even though there have been breakthroughs in conventional diagnostics and therapies. Alternatively, treatment with mild hyperthermia and herbal medicine treatment [selected using traditional Korean medicine theory 4 qi (cold, cool, warm and hot) and using the 5 senses of taste (sour, bitter, sweet, pungent and salty)], may be an option to promote cancer cell death in patients where the cancer is accessible.
Methods To investigate effect of combination treatment of herbal medicines and hyperthermia in vitro on cancer cell lines (ACHN, AGS, A549 and U937), the qualities of 38 medicinal herbs and sensitivity to mild hyperthermia (42 and 43°C) treatment were examined. An assay was performed to detect cell viability and proliferation (MTT) following exposure to medicinal herbs and hyperthermia.
Results Heat sensitizing herbal medicines were determined to be larger in the warm and hot groups of medicinal herbs (29.6%) than the groups which were neither warm nor hot (18.2%). In addition, the proportion of heat sensitizing effect with bitter and pungent flavors was 33.3 % and 32.1 %, respectively, greater than the average (26.3 %).
Conclusion In conditions of mild hyperthermia in cancer cell lines, incubation with herbal medicines caused cancer cell death in vitro. These results suggest that the use of traditional herbal medicines with warm, hot, pungent and bitter characteristics may be a useful treatment for cancer using conditions to induce mild hyperthermia and this requires further investigation.
Citations
Citations to this article as recorded by
Synergistic attenuation of complete freund’s adjuvant-induced inflammation in mice using shinbaro-pelubiprofen: a novel therapeutic complex Hyunseong Kim, Jin Young Hong, Wan-Jin Jeon, Hyun Kim, Changhwan Yeo, Junseon Lee, Yoon Jae Lee, In-Hyuk Ha Molecular Medicine.2025;[Epub] CrossRef